Table 1 Top 10 medicines by expenditure in 2010, central and local procurements
Medicine, strength, dose form | Therapeutic group | Expenditure in USD | Expenditure as % of general fund expenditure on medicines |
|---|---|---|---|
Neutral sol./isophane 30/70 human insulin 100 IU/ml 10 ml vial | Antidiabetic medicine | $ 1,478,122 | 9.6% |
Amoxicillin + clavulanic acid 500 + 125 mg tab | Antimicrobial | $ 973,521 | 6.3% |
Amoxicillin 250 mg/5 ml suspension | Antimicrobial | $ 716,602 | 4.7% |
Enalapril maleate 10 mg tab | Antihypertensive | $ 661,834 | 4.3% |
Amoxicillin 500 mg cap | Antimicrobial | $ 606,882 | 4.0% |
Amoxicillin + clavulanic acid 250 + 62 mg/5 ml suspension | Antimicrobial | $ 567,409 | 3.7% |
Cephalexin 500 mg cap | Antimicrobial | $ 473,402 | 3.1% |
Metformin HCL 500 mg tab | Antidiabetic medicine | $ 446,482 | 2.9% |
Gliclazide 80 mg tab | Antidiabetic medicine | $ 418,102 | 2.7% |
Paracetamol 250 mg/5 ml suspension | Antipyretic, analgesic | $ 411,496 | 2.7% |
Total | $ 6,753,853 | 44% |